Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.

By T. Oga, K. Nishimura, M. Tsukino, Susumu Sato, T. Hajiro. American Journal of Respiratory and Critical Care Medicine, 2003

645 citations recorded by the source corpus.

Subfields: General Health Professions, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/685db17f41ae67749788c0bbb95c9b607f6ceae6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In General Health Professions

1. D. Parums

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Barnes
3. R. Rodríguez-Roisín
4. Alvar Agusti
5. J. Soriano
6. W. Macnee
7. C. Jenkins
8. Sonia Buist

Citations in the corpus

• Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) (2008, background): “The same is the case for SGRQ scores (19) and exercise capacity (20).”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, positive): “Objectively measured exercise impairment, assessed by a reduction in self-paced walking distance (60) or during incremental exercise testing in a laboratory (61), is a powerful indicator of health status impairment and predictor of prognosis (62).”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, positive): “Объективно измеренное сниже ние толерантности к физической нагрузке по величине уменьшения максимального расстояния, проходимого пациентом в привычном для него темпе [149] или в про цессе лабораторного тестирования с возрастающей на грузкой [150], является информативным показателем ухудшения состоян”
• Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations (2012, neutral): “The literature supporting the use of CPX in patients with confirmed COPD or ILD is beginning to increase, producing compelling results in support of this form of ET for these patient populations.”
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. (2007, background): “Other important outcomes which provide prognostic information include the number and severity of exacerbations and hospitalizations (92-97), age (78,98-101), nutritional status (body weight [52], fat-free mass [53], body mass index [53,78,99,102]), the presence of gas exchange abnormalities (diffusi”
• Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease (2006, background): “As exercise capacity is thought to be a significant factor determining mortality in COPD (18) it perhaps follows that muscle weakness should also predict mortality.”
• Mortality in COPD: role of comorbidities (2006, background): “In one study [ 95 ], the authors analysed the relationship between exercise capacity, health status and mortality in 150 males with COPD, followed-up for 5 yrs.”